HESTERBIO

Hester Biosciences Share Price Hester Biosciences

₹1,394.45
22.15 (1.61%)
28 March, 2024 17:48 BSE: 524669 NSE: HESTERBIOISIN: INE782E01017

Start SIP in Hester Biosciences

Start SIP

Hester Biosciences Performance

Day Range

  • Low 1,338
  • High 1,434
₹ 1,394

52 Week Range

  • Low 1,293
  • High 1,940
₹ 1,394
  • Open Price1,376
  • Previous Close1,372
  • Volume20339

Hester Biosciences Share Price

  • Over 1 Month -0.62%
  • Over 3 Month -4.25%
  • Over 6 Month -16.9%
  • Over 1 Year -14.63%

Hester Biosciences Key Statistics

P/E Ratio 64.2
PEG Ratio -1.7
Market Cap Cr 1,186
Price to Book Ratio 4.1
EPS 38
Dividend 0.6
Relative Strength Index 50.47
Money Flow Index 54.42
MACD Signal -17.42
Average True Range 51.38
Hester Biosciences Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 66668061
Operating Expenses Qtr Cr 54546950
Operating Profit Qtr Cr 12121111
Depreciation Qtr Cr 3333
Interest Qtr Cr 1110
Tax Qtr Cr 2223
Net Profit Qtr Cr 6766
IndicatorMar 2023
Total Revenue Annual Cr 259
Operating Expenses Annual Cr 199
Operating Profit Annual in Cr 55
Depreciation Cr 10
Interest Annual Cr 6
Tax Annual Cr 12
Net Profit Annual Cr 32
IndicatorMar 2023
Cash from Operating Activity Annual Cr 33
Cash from Investing Activity Annual Cr -72
Cash from Financing Annual Activity Cr 41
Net Cash Flow Annual Cr 3
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 292
Fixed Assets Annual Cr 257
Total Non Current Assets Annual Cr 330
Total Current Assets Annual Cr 216
Total Assets Annual Cr 546
IndicatorMar 2023
Book Value Per Share Annual Rs 344
ROE Annual % 11
ROCE Annual % 12
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 24
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 67708867
Operating Expenses Qtr Cr 57577356
Operating Profit Qtr Cr 10131412
Depreciation Qtr Cr 4455
Interest Qtr Cr 2831
Tax Qtr Cr 2323
Net Profit Qtr Cr 4465
IndicatorMar 2023
Total Revenue Annual Cr 281
Operating Expenses Annual Cr 215
Operating Profit Annual in Cr 51
Depreciation Cr 21
Interest Annual Cr 9
Tax Annual Cr 12
Net Profit Annual Cr 27
IndicatorMar 2023
Cash from Operating Activity Annual Cr 24
Cash from Investing Activity Annual Cr -77
Cash from Financing Annual Activity Cr 42
Net Cash Flow Annual Cr -12
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 280
Fixed Assets Annual Cr 408
Total Non Current Assets Annual Cr 442
Total Current Assets Annual Cr 228
Total Assets Annual Cr 670
IndicatorMar 2023
Book Value Per Share Annual Rs 339
ROE Annual % 10
ROCE Annual % 9
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 25

Hester Biosciences Technicals

EMA & SMA

Current Price
₹1,394.45
22.15 (1.61%)
pointer
  • Bullish Moving Average
  • ___
  • 9
  • Bearish Moving Average
  • ___
  • 7
  • 20 Day
  • ₹1,385.02
  • 50 Day
  • ₹1,419.58
  • 100 Day
  • ₹1,475.07
  • 200 Day
  • ₹1,566.22
  • 20 Day
  • ₹1,379.19
  • 50 Day
  • ₹1,424.96
  • 100 Day
  • ₹1,472.90
  • 200 Day
  • ₹1,585.63

Hester Biosciences Resistance and Support

PIVOT
₹1,388.84
Resistance
First Resistance 1,439.62
Second Resistance 1,484.78
Third Resistance 1,535.57
RSI 50.47
MFI 54.42
MACD Single Line -17.42
MACD -10.40
Support
First Resistance 1,343.67
Second Resistance 1,292.88
Third Resistance 1,247.72

Hester Biosciences Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 33,347 2,949,876 88.46
Week 21,770 1,762,023 80.94
1 Month 10,645 860,408 80.83
6 Month 7,694 529,649 68.84

Hester Biosciences Result Highlights

Hester Biosciences Synopsis

NSE-Medical-Ethical Drugs

Hester Biosciences L is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 254.00 Cr. and Equity Capital is Rs. 8.51 Cr. for the Year ended 31/03/2023. Hester Biosciences Ltd. is a Public Limited Listed company incorporated on 29/04/1987 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L99999GJ1987PLC022333 and registration number is 022333.
Market Cap 1,184
Sales 273
Shares in Float 0.39
No of funds 15
Yield 0.58
Book Value 3.99
U/D Vol ratio 0.9
LTDebt / Equity 29
Alpha -0.12
Beta 0.44

Hester Biosciences

Owner NameDec-23Sep-23Jun-23Mar-23
Promoters 53.73%53.73%53.73%53.73%
Mutual Funds
Foreign Portfolio Investors 0.43%0.42%0.45%0.45%
Individual Investors 33.3%33.19%33.36%33.02%
Others 12.54%12.66%12.46%12.8%

Hester Biosciences Management

Name Designation
Dr. Bhupendra Gandhi Chairman
Mr. Rajiv Gandhi Managing Director & CEO
Ms. Priya Gandhi Executive Director
Mr. Ravin Gandhi Director
Mr. Sanjiv Gandhi Director
Mr. Ashok Bhadakal Independent Director
Ms. Sandhya Patel Independent Director
Mr. Ameet Desai Independent Director
Ms. Nina Gandhi Alternate Director

Hester Biosciences Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Hester Biosciences Corporate Action

Date Purpose Remarks
2024-02-02 Quarterly Results
2023-11-07 Quarterly Results
2023-08-08 Quarterly Results
2023-05-17 Audited Results & Final Dividend
2023-01-31 Quarterly Results

Hester Biosciences MF Shareholding

Name Amount(cr)

Hester Biosciences FAQs

What is Share Price of Hester Biosciences ?

Hester Biosciences share price is ₹1,394 As on 28 March, 2024 | 17:34

What is the Market Cap of Hester Biosciences ?

The Market Cap of Hester Biosciences is ₹1186.2 Cr As on 28 March, 2024 | 17:34

What is the P/E ratio of Hester Biosciences ?

The P/E ratio of Hester Biosciences is 64.2 As on 28 March, 2024 | 17:34

What is the PB ratio of Hester Biosciences ?

The PB ratio of Hester Biosciences is 4.1 As on 28 March, 2024 | 17:34

Q2FY23